Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

The treatment combination is effective and generally safe for lung cancer.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.